Microbiome Times Magazine https://validator.w3.org/feed/docs/rss2.html Events Microbiotica Collaborates with University of Adelaide to Develop a Novel Microbial Therapy for Ulcerative Colitis ExeGi Pharma Launches High Potency Veterinary Probiotic To Help Manage GI Tract Illnesses In Dogs BiomX Licenses Novel Bacterial Targets for the Treatment of Inflammatory Bowel Disease Brazilian Health Authorities Recognize Bifidobacterium Lactis HN019™ as Beneficial to Gastrointestinal Health Da Volterra Announces Enrollment of First Patients in SHIELD, a Phase 2 Clinical Trial with DAV132, a Novel Microbiota Protective Therapy Webinar: Improving Ulcerative Colitis Symptoms with Probiotics MicroBiome Therapeutics Launches Clinically-Tested Dietary Supplement Engineered to Modulate the Gut Microbiome The secret to longevity is in the microbiome and the gut Parkinson’s Institute and Clinical Center and Axial Biotherapeutics Announce Collaboration to Target Gastrointestinal Metabolites That May Contribute to Parkinson’s Disease Finch Therapeutics and Takeda Announce Global Collaboration to Develop Microbiome Therapeutics in Inflammatory Bowel Disease (IBD) Study into the causes of Crohn’s disease hits major milestone Bactolife Raises EUR 30 million in Series A Financing Vedanta Biosciences Receives Award from the Crohn’s & Colitis Foundation to Advance a Microbiome-Derived Therapeutic Program for Interception and Treatment of Inflammatory Bowel Disease 4D Pharma plc Announces First Patient Enrolment in Blautix IBS Phase II study BiomX Enters Collaboration with Johnson & Johnson Innovation for Discovery of Microbiome-based Biomarkers for IBD Prescient Medicine and Metabiomics Partner to Develop New Gastrointestinal Health Tests to Detect Colon Polyps Enterome Signs Global Licensing, Co-development and Co-promotion Agreement with Takeda for the Treatment of Crohn’s Disease Vedanta Biosciences Announces Initiation of Phase 1 Clinical Study with Janssen of Microbiome-Derived Product Candidate for IBD Nextbiotix raises € 7m in a Series A round to tackle inflammatory bowel diseases Major Breakthrough in Poultry Nutrition: DSM and Novozymes launch Balancius™ 4D Pharma Provides Clinical Update and Publication of Studies on Thetanix Symberix Announces Non-Dilutive Funding Support for Lead Programs Rebiotix and Microbiome Insights Collaborate on a Microbiome IBD Tool for Clinical Development Trans-Atlantic study finds promising results with high potency probiotic, in dogs with severe form of acute diarrhoea Seres Therapeutics Announces Initiation of SER-287 Phase 2B ECO-RESET Clinical Study for Ulcerative Colitis More than 100 new gut bacteria discovered in human microbiome Microbiome Profiling Techniques Reveal Effects of Iron Fortification on the Infant Gut Microbiome New ELISA Blood Test Offers Important Insights to Patients with Scleroderma and Systemic Sclerosis KNOW Bio Announces Creation of Digestive Health Therapeutics, Inc. 5-minute Microbiome Science Roundup: April 2019 New Findings from Human Microbiome Project Reveal how Microbiome is Disrupted During IBD 3D printed pill samples gut microbiome to aid diagnosis and treatment Five-minute Microbiome Science Roundup: May 2019 Precision editing of gut bacteria reduces cancer in mice Biomica Advances to Pre-Clinical Studies in its IBD Program Gut bacteria ‘fingerprint’ predicts radiotherapy side effects Ritter Pharmaceuticals Announces Last Patient Last Visit in its Phase 3 “Liberatus” Clinical Trial of RP-G28 for Lactose Intolerance Seres Therapeutics First Quarter Financial Results and Clinical Pipeline Progress Half of all commonly used drugs profoundly affecting the gut microbiome, warn experts BioGaia’s probiotic reduces inflammation in patients with diverticulitis Colorectal cancer surgery: Gut microbiota helps healing Towards a diagnostic test: the gut microbiome as a clinical target for screening for colorectal cancer Digbi Health Raises $5.4 Million in Series A Funding to Reverse Obesity and Associated Inflammatory Digestive and Skin Illnesses Home The Importance of Scale in Evaluating the Gut Microbiome Fecal transplantation to treat patients with Parkinson’s disease: Hope or hype? Cerebiome® exerts a positive influence on the gut microbiota of individuals with mild anxiety, new study finds Scientists find gut-brain link that may affect behavior in children with autism All News